CA 19-9 is a tumor marker primarily used in the management and monitoring of pancreatic cancer, although it can also be elevated in other conditions such as liver disease and gastrointestinal cancers. Its levels can help assess treatment response and detect cancer recurrence, but it is not specific enough for screening or diagnosis due to possible elevations in non-cancerous conditions.